Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Breast Cancer Res Treat. 2020 Oct 27;185(3):841–849. doi: 10.1007/s10549-020-05984-w

Figure 2. Recurrence-Free Survival Curve for Black and White Patients by Breast Cancer Subtype.

Figure 2.

Cox proportional hazards models were used adjusting for age at diagnosis, cancer stage, PR status and comorbidities in HR+/HER2− and HR+/HER2+ subtypes; adjusting for age at diagnosis, cancer stage and comorbidities in HR−/HER2+ and TNBC subtypes. The adjusted hazard ratio (95% CI) was 1.53 (1.22–1.91) for HR+/HER2− subtype, 1.04 (0.61–1.77) for HR+/HER2+ subtype, 3.00 (1.36–6.60) for HR−/HER2+ subtype, and 1.06 (0.75–1.50) for TNBC subtype.